Characterization of human malignant mesothelioma cell lines orthotopically implanted in the pleural cavity of immunodeficient mice for their ability to grow and form metastasis

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Martarelli, Daniele ^a   Catalano, Alfonso ^b,c   Procopio, Antonio ^b,c   Orecchia, Sara ^d   Libener, Roberta ^d   Santoni, Giorgio ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c INRCA   (Italy)

^d Pathology Unit   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CANCER CELL CULTURE; CELL GROWTH; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIAPHRAGM; DISEASE COURSE; DISEASE MODEL; GROWTH RATE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LUNG PARENCHYMA; LYMPH NODE METASTASIS; MALE; MALIGNANT MESOTHELIOMA; MEDIASTINUM; METASTASIS POTENTIAL; MOUSE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PHENOTYPE; PLEURA CAVITY; PLEURA MESOTHELIOMA; PNEUMOTHORAX; REPRODUCIBILITY; TIME; TUMOR GROWTH; VISCERAL METASTASIS;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; MALE; MESOTHELIOMA; MICE; MICE, NUDE; NEOPLASM METASTASIS; PLEURAL EFFUSION; PLEURAL NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 33745678744     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-130     Document Type: Article

References (15)

1. Antman KH: Natural history and epidemiology of malignant mesothelioma. Chest 1993, 103:73S-76S.
2. Edwards JG, Swinson DE, Jones JL, Muller S, Waller DA, O'Byrne KJ: Tumor necrosis correlates with angiogenesis and is a predictor of poor prognosis in malignant mesothelioma. Chest 2003, 124:1916-1923.
3. Stewart JH, Nguyen DM, Chen GA, Schrump DS: Induction of apoptosis in malignant pleural mesothelioma cells by activation of the Fas (Apo-1/ CD95) death-signal pathway. J Thorac Cardiovasc Surg 2002, 123:295-302.
4. Rippo MR, Moretti S, Vescovi S, Tomasetti M, Orecchia S, Amici G, Catalano A, Procopio A: FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells. Oncogene 2004, 23:7753-7760.
5. Edwards JG, Cox G, Andi A, Jones JL, Walker RA, Waller DA, O'Byrne KJ: Angiogenesis is an independent prognostic factor in malignant mesothelioma. Br J Cancer 2001, 85:863-868.
6. Catalano A, Romano M, Robuffo I, Strizzi L, Procopio A: Methionine aminopeptidase-2 regulates human mesothelioma cell survival: role of Bcl-2 expression and telomerase activity. Am J Pathol 2001, 159:721-731.
7. Sterman DH, Albelda SM: Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma. Respirology 2005, 10:266-283.
8. Le Pimpec-Barthes F, Bernard I, Abd Alsamad I, Renier A, Kheuang L, Fleury-Feith J, Devauchelle P, Quintin Colonna F, Riquet M, Jaurand MC: Pleuro-pulmonary tumours detected by clinical and chest X-ray analyses in rats transplanted with mesothelioma cells. Br J Cancer 1999, 81:1344-1350.
9. Colt HG, Astoul P, Wang X, Yi ES, Boutin C, Hoffman RM: Clinical course of human epithelial-type malignant pleural mesothelioma replicated in an orthotopic-transplant nude mouse model. Anticancer Res 1996, 16:633-639.
10. Nakataki E, Yano S, Matsumori Y, Goto H, Kakiuchi S, Muguruma H, Bando Y, Uehara H, Hamada H, Kito K, Yokoyama A, Sone S: Novel orthotopic implantation model of human malignant pleural mesothelioma (EHMES-10 cells) highly expressing vascular endothelial growth factor and its receptor. Cancer Sci 2006, 97:183-191.
11. Orengo AM, Spoletini L, Procopio A, Favoni RE, De Cupis A, Ardizzoni A, Castagneto B, Ribotta M, Betta PG, Ferrini S, Mutti L: Establishment of four new mesothelioma cell lines: characterization by ultrastructural and immunophenotypic analysis. Eur Respir J 1999, 13:527-534.
12. Pass HI, Stevens EJ, Oie H, Tsokos MG, Abati AD, Fetsch PA, Mew DJ, Pogrebniak HW, Matthews WJ: Characteristics of nine newly derived mesothelioma cell lines. Ann Thorac Surg 1995, 59(4):835-844.
13. King JE, Thatcher N, Pickering CA, Hasleton PS: Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published data. Histopathology 2006, 48:223-232.
14. Ordonez NG: Application of mesothelin immunostaining in tumor diagnosis. Am J Surg Pathol 2003, 27:1418-1428.
15. Nowak AK, Lake RA, Kindler HL, Robinson BWS: New approaches for mesothelioma: biologics, vaccines, gene therapy and other novel agents. Semin Oncol 2002, 29:82-96.